The University of British Columbia's Collaboration for Outcomes Research and Evaluation (CORE) group addresses the need for clinical and economic research, and education in pharmaceutical outcomes assessment. The CORE team is a multidisciplinary group of researchers with expertise in clinical pharmacy, pharmacoepidemiology, health economics, health services research, program evaluation and health promotion research.
CORE strives to provide evidence which will maximize the clinical, quality of life, and economic benefits of drug therapy, while minimizing associated risks. This is achieved through independent research and research collaborations with pharmaceutical and health outcomes researchers throughout North America and Europe.
"IMPROVE HEALTH-CARE RELATED OUTCOMES TO DRUG THERAPY THROUGH THE APPLICATION OF THE BEST IN RESEARCH, EDUCATION, AND PRACTICE ENHANCEMENT STRATEGIES."
Word from the Director
Over this past year, CORE has continued to evolve and develop. Investigators from CORE published twenty-eight peer-reviewed papers in high caliber journals such as the Lancet, the Archives of Internal Medicine, and the American Journal of Human Genetics to name a few. We were fortunate to continue to attract peer-reviewed funding from very competitive sources and have recently finished a number of high impact projects including our evaluation of pharmacist surveillance for drug safety from a grant provided through the Drug Safety and Effectiveness Network (DSEN), Health Canada/CIHR.
CORE members continued to teach pharmacotherapeutics, health policy and health economics to undergraduate pharmacy students, and continued providing the Critical Evaluation of the Pharmacotherapy Literature to Doctor of Pharmacy students. In addition, CORE members collaborated with individuals from the Centre for Clinical Epidemiology and Evaluation and CHEOS to deliver an intensive two day workshop on health technology assessment and economic evaluation. click here for more details